Colton Groome Financial Advisors, LLC Bristol Myers Squibb CO Transaction History

Colton Groome Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $12,614 - $14,006	-198 Reduced 5.51%	3,394 $217,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $11,236 - $12,744	171 Added 5.0%	3,592 $248,000
Q4 2022 Jan 25, 2023	SELL	$68.48 - $81.09 $1,301 - $1,540	-19 Reduced 0.55%	3,421 $0
Q3 2022 Oct 20, 2022	SELL	$0.13 - $76.84 $20 - $12,371	-161 Reduced 4.47%	3,440 $245,000
Q2 2022 Jul 26, 2022	BUY	$72.62 - $79.98 $34,857 - $38,390	480 Added 15.38%	3,601 $277,000
Q1 2022 Apr 18, 2022	BUY	$61.48 - $73.72 $191,879 - $230,080	3,121 New	3,121 $228,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Colton Groome Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Colton Groome Financial Advisors, LLC with notifications on news.